![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
OSE Immunotherapeutics KOL Investor Webinar on the Therapeutic Landscape and Unmet Medical Needs in Non-Small Cell Lung Cancer by Dr Stephen Liu and Prof Benjamin Besse OSE Immunotherapeutics...
OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant OSE Immunotherapeutics and Nantes University...
Informations relatives au nombre total de droits de vote et d’actions composant le capital Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes...
OSE Immunotherapeutics Provides Business and Corporate Update OSE Immunotherapeutics Provides Business and Corporate Update Three pharmaceutical agreements signed during the last three...
Mise à disposition des documents préparatoires à l’Assemblée générale mixte du 19 juin 2024 Mise à disposition des documents préparatoires à l’Assemblée générale mixte du 19 juin 2024...
OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases OSE Immunotherapeutics and Boehringer...
Informations relatives au nombre total de droits de vote et d’actions composant le capital Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes...
Mise à disposition du Document d’Enregistrement Universel incluant le Rapport Financier 2023 Mise à disposition du Document d’Enregistrement Universel incluant le Rapport Financier 2023...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 4.12 | 4.12 | 4.12 | 4431 | 4.12 | DE |
4 | 0 | 0 | 4.12 | 4.12 | 4.12 | 1532 | 4.12 | DE |
12 | 0 | 0 | 4.12 | 4.12 | 4.12 | 643 | 4.12 | DE |
26 | 0 | 0 | 4.12 | 4.12 | 4.12 | 1365 | 4.12 | DE |
52 | 0 | 0 | 4.12 | 4.12 | 4.12 | 3210 | 4.12 | DE |
156 | 0 | 0 | 4.12 | 4.12 | 4.12 | 2438 | 4.12 | DE |
260 | 0 | 0 | 4.12 | 4.12 | 4.12 | 3325 | 4.12 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions